Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on: April 22,2024

Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on:April 22,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on: February 18,2024

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

Updated on:February 18,2024

Researchers identify potential genetic variants linked to increased cancer risk in children with birth defects

by Children's Hospital of PhiladelphiaDemographic information of the cohort. aPhenotype information of the discovery cohort; bPhenotype information of the validation cohort; c&nbs

Updated on: February 01,2024

Researchers identify potential genetic variants linked to increased cancer risk in children with birth defects

by Children's Hospital of PhiladelphiaDemographic information of the cohort. aPhenotype information of the discovery cohort; bPhenotype information of the validation cohort; c&nbs

Updated on:February 01,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on: January 29,2024

Researchers identify a promising new drug target for rare liver cancer

by Rockefeller UniversityCredit: Pixabay/CC0 Public DomainAs a rare and lethal liver cancer that disproportionately harms young adults, fibrolamellar carcinoma is nearly incurable. Surgery can re

Updated on:January 29,2024

Can liquid biopsies compete with scopes and scans in cancer diagnosis?

by Ricki Lewis,Public Library of ScienceInvasion and metastasis.March isNational Colorectal Cancer Awareness Month, the perfect time to bring up the value of colonoscopies and mammograms.

Updated on: May 05,2024

Can liquid biopsies compete with scopes and scans in cancer diagnosis?

by Ricki Lewis,Public Library of ScienceInvasion and metastasis.March isNational Colorectal Cancer Awareness Month, the perfect time to bring up the value of colonoscopies and mammograms.

Updated on:May 05,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Updated on: June 15,2024

Researchers move closer to 'magic' cancer treatment

by Brent Wittmeier,University of AlbertaU of A researcher Khaled Barakat with the IBM supercomputer his team used to develop a small molecule that could help the body fight cancer by allowing th

Updated on:June 15,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on: August 03,2024

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Updated on:August 03,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on: April 28,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on:April 28,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Updated on: March 30,2024

ASCO: ovarian suppression + tamoxifen ups breast CA survival

(HealthDay)—The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published o

Updated on:March 30,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul

Updated on: May 27,2024

Study confirms effectiveness of newer arthritis meds

by Amy NortonNewer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.The study, of 622 adul

Updated on:May 27,2024